Neoadjuvant immunotherapy for melanoma is now ready for clinical practice.
Garbe C, Dummer R, Amaral T, Amaria RN, Ascierto PA, Burton EM, Dreno B, Eggermont AMM, Hauschild A, Hoeller C, Kaufmann R, Lebbe C, Mandala M, Menzies AM, Moreno D, Michielin O, Nathan P, Patel SP, Robert C, Schadendorf D, Lorigan PC, Scolyer RA, Tawbi HA, van de Wiel BA, Blank C, Long GV.
Garbe C, et al. Among authors: long gv.
Nat Med. 2023 Jun;29(6):1310-1312. doi: 10.1038/s41591-023-02336-1.
Nat Med. 2023.
PMID: 37193799
No abstract available.